The biomanufacturing sector for advanced therapies is experiencing rapid growth and an escalating demand for personnel with specialized skill sets compared to conventional biopharmaceutical manufacturing. To address this need, OBIO® and CATTI have partnered to deliver the Biomanufacturing for Advanced Therapies Training Program, including cell and gene therapy (CGT), funded by Upskill Canada [powered by Palette Skills] and the Government of Canada.
The program focuses on both conceptual and practical skills essential to the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs), with a curriculum developed through extensive collaborations with companies in the sector developing CGTs and tailored to meet their specialized workforce needs.
Upcoming sessions:
December 8-12 | Aseptic Techniques & Cell Culture – Guelph
January 19-23 | Closed System Manufacturing, CAR-T and Immunotherapies – Guelph
January 26-30 | Aseptic Techniques & Cell Culture – Montreal
February 2-6 | Aseptic Techniques & Cell Culture – Vancouver
February 9-13 | Aseptic Techniques & Cell Culture – Carleton (Ottawa)
February 23-27 | Closed System Manufacturing, CAR-T and Immunotherapies – Guelph
March 2-6 | Quality Control & Microbiology – Guelph
March 9-13 | Closed System Manufacturing, CAR-T and Immunotherapies – Guelph
March 16-20 | Aseptic Techniques & Cell Culture – Guelph